A major vaccine advancement could protect some of the world’s rarest creatures from a deadly disease that’s killed hundreds of millions of birds and animals. Australia and New Zealand are the last major destinations where a highly virulent strain of avian influenza, HPAI, has not spread, and both countries are preparing for its inevitable arrival. Because the two countries’ ecosystems …
Read More »Tag Archives: trial
Sean ‘Diddy’ Combs’ request for acquittal or new trial should be rejected, prosecutors say
Sean ‘Diddy’ Combs’ request for an acquittal or a new trial should be quickly rejected, prosecutors said in a new court filing almost three weeks after the music mogul was convicted of two charges related to prostitution. In a filing made public just before midnight on Wednesday, prosecutors said there were no legal grounds for the court to grant Combs’ …
Read More »‘Truly a groundbreaking discovery’: U.Va. gets funding for clinical trial to stop sepsis
A team at the University of Virginia has developed a monoclonal antibody to stop sepsis, the leading cause of death in U.S. hospitals. There is good news from Virginia when it comes to the deadly infection sepsis. “This is truly a groundbreaking discovery,” said Jianjie Ma, a professor in the department of surgery at the University of Virginia. “Sepsis is …
Read More »Viking Therapeutics oral weight loss drug hits mark in mid-stage trial
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. A new oral weight loss drug developed by Viking Therapeutics hit the mark in a mid-stage clinical trial, but the …
Read More »Viking Therapeutics loses a third of its value after oral weight-loss drug trial – MarketWatch
Viking Therapeutics loses a third of its value after oral weight-loss drug trial MarketWatch Viking Therapeutics shares fall 40% on disappointing obesity pill trial data CNBC Viking Therapeutics (VKTX) Stock Fell More Than 30%. What Sent It Crashing. Barron’s Viking’s oral pill reduces up to 12.2% weight but shares slump on higher patient exits Reuters Viking Therapeutics Rises as Phase 3 Trials and Oral …
Read More »Viking Therapeutics stock falls 37% on high dropout rate in obesity trial
Investing.com — Viking Therapeutics (NASDAQ:VKTX) stock plunged as much as 37% Tuesday after revealing results from its Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment, while Eli Lilly (NYSE:LLY) shares gained 1.5% as analysts pointed to competitive advantages. The trial demonstrated that Viking’s oral tablet formulation of VK2735, a dual GLP-1 and GIP receptor agonist, met its primary …
Read More »Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
Study Achieves Primary and Secondary Endpoints, Demonstrating Statistically Significant Reductions in Body Weight with Once-Daily VK2735 Dosing as Compared to Placebo Up to 12.2% (26.6 lbs) Mean Weight Loss Observed After 13 Weeks of VK2735 Treatment Compared with 1.3% (2.9 lbs) for Placebo Exploratory Assessment of Low Dose Maintenance Treatment Demonstrates Positive Proof of Concept VK2735 Shown to be Safe …
Read More »Boy, 12, with rare genetic skin disorder can now play football after breakthrough medical trial
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know …
Read More »The Rockefeller University » Immunotherapy drug eliminates aggressive cancers in clinical trial
Histology image of a patient whose metastatic cancer went into complete remission after receiving a new immunotherapy treatment (Ravetch lab) Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise—and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact …
Read More »Trial shows fragility of limits on US military's domestic role – Reuters
Trial shows fragility of limits on US military’s domestic role Reuters Trial over California National Guard deployment concludes as judge questions limits of president’s authority CBS News Judge weighs whether Trump violated federal law by deploying National Guard to Los Angeles AP News National Guard rehearsed show of force against immigration raid protesters in LA, general testifies NBC Los Angeles Federal judge questions if …
Read More »